Bolin, S., Borgenvik, A., Persson, C. U., Sundström, A., Qi, J., Bradner, J. E., . . . Swartling, F. J. (2018). Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma. Oncogene.
Citação norma ChicagoBolin, Sara, et al. "Combined BET Bromodomain and CDK2 Inhibition in MYC-driven Medulloblastoma." Oncogene 2018.
ציטוט MLABolin, Sara, et al. "Combined BET Bromodomain and CDK2 Inhibition in MYC-driven Medulloblastoma." Oncogene 2018.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.